Matches in Nanopublications for { ?s ?p "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP243610.RAULyrJC_uNap7UqnaVgwHahemO6rFfAWBTijpushJiDA130_assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243610.RAULyrJC_uNap7UqnaVgwHahemO6rFfAWBTijpushJiDA130_provenance.
- NP949509.RAYOvubhRDPw9YsjFnKD4vjTZIfsV3Z13DCWH71SkudiE130_assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949509.RAYOvubhRDPw9YsjFnKD4vjTZIfsV3Z13DCWH71SkudiE130_provenance.
- assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1307692.RABsduJMmT-uBXBveoka--DrEMWhLOBb3eJcAtTvZlRSw130_assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307692.RABsduJMmT-uBXBveoka--DrEMWhLOBb3eJcAtTvZlRSw130_provenance.
- NP1307694.RAKw4YWN1zRjrZSGU4eAKsyzpLD3BiNAUZLcIElzNd24k130_assertion description "[These data are consistent with the concept that apoA-I(Tangier) is functionally and metabolically distinct from normal apoA-I, and is the cause of the striking hypercatabolism of apoA-I and apoA-II, and the lipoprotein abnormalities observed in Tangier disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1307694.RAKw4YWN1zRjrZSGU4eAKsyzpLD3BiNAUZLcIElzNd24k130_provenance.